2 more hospitals get compassionate permit for ivermectin use vs. COVID-19 —FDA
By JULIA MARI ORNEDO, GMA News Published April 27, 2021 10:12am Two more hospitals have been granted compassionate special permit (CSP) for the use of the antiparasitic drug ivermectin on COVID-19 patients, the Food and Drug Administration (FDA) said Tuesday. There are now five hospitals that have been issued a CSP for ivermectin, FDA chief Eric Domingo confirmed to GMA News Online. Domingo previously made clear that a CSP is not a marketing authorization, meaning ivermectin cannot be sold commercially yet. A CSP is also not an FDA endorsement of a drug’s quality and efficacy. â€...